We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
+40.57%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$330M
AUM Growth
+$35.8M
Cap. Flow
+$36.1M
Cap. Flow %
10.93%
Top 10 Hldgs %
97.93%
Holding
14
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
TNGX icon
Tango Therapeutics
TNGX
+$33.7M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.66M

Top Sells

Rank Stock Value
1
PMVP icon
PMV Pharmaceuticals
PMVP
+$344K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.6B
$134M 40.59%
4,839,529
– –
TNGX icon
2
Tango Therapeutics
TNGX
$4.21B
$62.3M 18.88%
+5,533,980
New +$33.7M
TYRA icon
3
Tyra Biosciences
TYRA
$1.84B
$34.7M 10.51%
2,518,582
– –
EQRX
4
DELISTED
EQRx, Inc. Common Stock
EQRX
$29.1M 8.82%
13,104,424
– –
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.2B
$25.9M 7.86%
4,285,714
– –
CGEM icon
6
Cullinan Oncology
CGEM
$1.04B
$11.1M 3.35%
1,221,145
– –
RLAY icon
7
Relay Therapeutics
RLAY
$4.01B
$10.1M 3.05%
1,196,409
+247,750
+26% +$2.66M
SPRY icon
8
ARS Pharmaceuticals
SPRY
$574M
$7.22M 2.19%
1,910,029
– –
ARVN icon
9
Arvinas
ARVN
$535M
$5.64M 1.71%
287,251
– –
KNTE
10
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$3.26M 0.99%
2,329,480
– –
PMVP icon
11
PMV Pharmaceuticals
PMVP
$57.1M
$2.59M 0.78%
421,284
-50,000
-11% -$344K
KRON
12
DELISTED
Kronos Bio
KRON
$1.89M 0.57%
1,451,537
– –
THRX
13
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$1.64M 0.5%
611,310
– –
CCCC icon
14
C4 Therapeutics
CCCC
$391M
$699K 0.21%
375,857
– –

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q3 2023 Portfolio in Review

As of Q3 2023, Nextech Invest held 14 positions worth $330M, up 12% from $294M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Nextech Invest deployed $36.1M of net new capital in Q3 2023, opening 1 new position and adding to 1 existing holding. Its largest new stake was Tango Therapeutics: 5,533,980 shares worth $62.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was PMV Pharmaceuticals, an estimated $344K trimmed.

  • Nextech Invest's largest Q3 2023 buy was Tango Therapeutics: 5,533,980 shares worth $62.3M.
  • Nextech Invest added most to Relay Therapeutics in Q3 2023, an estimated $2.66M increase.
  • Nextech Invest's biggest Q3 2023 reduction was PMV Pharmaceuticals, cutting an estimated $344K.
  • Nextech Invest's ten largest holdings make up 98% of its $330M portfolio in Q3 2023.
  • Nextech Invest opened 1 new position and closed 0 in Q3 2023.
  • Nextech Invest's portfolio value rose 12% quarter-over-quarter to $330M.

Based on Nextech Invest's 13F filing for Q3 2023, filed 14 Nov 2023.